Corbion and Nestlé have entered into a joint agreement to develop a platform of algae-based ingredient rich in protein and micronutrients to delivery sustainable and nutritious plant-based products.
Photo © iStockphoto.com
Corbion (Amsterdam, The Netherlands) and Nestlé (Vevey, Switzerland) have entered into a joint agreement to develop a platform of algae-based ingredient rich in protein and micronutrients to delivery sustainable and nutritious plant-based products. Microalgae is a vegan source of protein, healthy lipids, and other micronutrients that can be produces with a low carbon, land, and water footprint.
Corbion brings to the table its microalgae and fermentation capabilities while Nestlé brings its expertise in development of plant-based products. Nestlé's plant-based portfolio includes various beverages such as almond-, coconut-, and oat-based creamers and coffee mixes, non-dairy ice cream, as well as a range of pea and soy-based meat alternatives and prepared dishes.
“We are actively exploring the use of microalgae as an alternative protein and micronutrient source for exciting plant-based products,” said Stefan Palzer, Nestlé chief technology officer, in a press release. “Through the partnership with Corbion, we will be able to use great-tasting, nutritious microalgae-based ingredients to innovate across our different product categories.”
“We are excited to partner with Nestlé to develop the next generation of algae-based ingredients,” added Marc den Hartog, executive vice president, Innovation Platforms at Corbion, in a press release. “Corbion has already demonstrated the value of algae in several high-value food and feed applications. This new protein partnership with Nestlé has the potential to open important avenues for algae-based products into large global markets.”
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.